Local News: Ashburn, VA 

 | 

Sign Up

 | 

Sign In

Keryx Biopharmaceuticals Newswire

Comprehensive Real-Time News Feed for Keryx Biopharmaceuticals.

Results 1 - 20 of 167 in Keryx Biopharmaceuticals

  1. NASDAQ Active Stock Watch List: Keryx Biopharmaceuticals Inc....Read the original story

    Tuesday May 14 | SBWire

    Equity Profile Report expands its NASDAQ Active Stock Weekly Watch List adding Keryx Biopharmaceuticals Inc.

    Comment?

  2. Keryx Biopharmaceuticals Inc. (NASDAQ:KERX), Ariad Pharmaceuticals...Read the original story

    Tuesday May 14 | SBWire

    Growing Stock Report expands its Biotech Gainers Weekly Watch List adding Keryx Biopharmaceuticals Inc.

    Comment?

  3. 3 Biotech Stocks With PotentialRead the original story w/Photo

    Tuesday May 14 | Seeking Alpha

    ... recent examples of the high levels of volatility that small cap biotech investing can throw at you. Keryx Biopharmaceuticals ( KERX ) is an early stage biotech company that had been focusing on developing a treatment for kidney disease, called ...

    Comment?

  4. Technical Stock Breakout Watch: Keryx BiopharmaceuticalsRead the original story

    Monday May 13 | SBWire

    The online StockConsultant latest screen has found a biotech company that provides drugs for the treatment of cancer and renal diseases Keryx Biopharmaceuticals stock under a breakout watch above 8.77. KERX stock price is up 5.6% to 8.68 on 50.3% higher volume and is trying to break over double resistance.

    Comment?

  5. Keryx Biopharmaceutical's CEO Discusses Q1 2013 Results - Earnings Call TranscriptRead the original story

    Wednesday May 8 | Seeking Alpha

    Greetings and welcome to the Keryx Biopharmaceuticals Investor Conference Call. At this time, all participants are in a listen-only mode.

    Comment?

  6. Keryx: A Small Biotech With Many CatalystsRead the original story

    Wednesday May 8 | Seeking Alpha

    ... holding the shares of Sarepta Therapeutics ( SRPT ), which we reviewed unfavorably on April 24th . Keryx Biopharmaceuticals is developmental stage biopharmaceutical company that's focused on the acquisition, development and commercialization of ...

    Comment?

  7. Keryx Biopharmaceuticals Announces First Quarter 2013 Financial ResultsRead the original story

    Wednesday May 8 | BioSpace

    Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! NEW YORK, May 6, 2013 /PRNewswire/ -- Keryx Biopharmaceuticals, Inc.

    Comment?

  8. Keryx Biopharmaceuticals (KERX) Posts Quarterly Earnings, Misses Estimates By $0.02 EPSRead the original story

    Wednesday May 8 | AmericanBankingNews.com

    Keryx Biopharmaceuticals issued its quarterly earnings data on Wednesday. The company reported EPS for the quarter, missing the Thomson Reuters consensus estimate of by $0.02, AnalystRatings.Net reports.

    Comment?

  9. Whisper Number Impact: Earnings Preview For Keryx BiopharmaceuticalsRead the original story

    Tuesday May 7 | Seeking Alpha

    Keryx Biopharmaceuticals is expected to report earnings on Wednesday, May 8th. The whisper number is -$0.01, in-line with the analysts' estimate.

    Comment?

  10. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2013 Financial ResultsRead the original story

    Tuesday May 7 | Freshnews

    Keryx Biopharmaceuticals, Inc. , a biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of renal disease , today announced its results for the first quarter ended March 31, 2013.

    Comment?

  11. GSK, AZN, KERX, and RPTP Early Briefing and ReviewRead the original story

    Thursday May 2 | BayStreet.ca

    ... data. Among the major movers were GlaxoSmithKline Plc (NYSE: GSK), AstraZeneca Plc (NYSE: AZN), Keryx Biopharmaceuticals Inc. (NASDAQ: KERX), and Raptor Pharmaceutical Corp. (NASDAQ: RPTP). StockCall has released free charting and technical research ...

    Comment?

  12. Key ETF Performance In April And Year To DateRead the original story

    Tuesday Apr 30 | Seeking Alpha

    The first four months of the trading year are now behind us, and the "big three" of U.S. market indices are all now up more than 10% year to date.

    Comment?

  13. NewLink Genetics: Looking To Join The Industry's Largest MoversRead the original story

    Monday Apr 29 | Seeking Alpha

    ... look at the last year alone, there have been countless valuation-changing moves in biotechnology. Keryx Biopharmaceuticals ( KERX ) saw a two-day period where its stock more than doubled after reporting Phase 3 data. Sarepta Therapeutics ( SRPT ) ...

    Comment?

  14. Hot Stocks: Whirlpool Corporation, Allegheny Technologies...Read the original story

    Thursday Apr 25 | SBWire

    ... rating in a report released on April 16. How Should Investors Trade SRPT Now? Find Out Here Keryx Biopharmaceuticals (NASDAQ:KERX) shares declined 2.53% to $8.10. The company, on Marc h 11, announced its results for the fourth quarter and year ended ...

    Comment?

  15. Keryx Biopharmaceuticals and Nuance Communications Analysis:Read the original story

    Tuesday Apr 23 | SBWire

    Keryx Biopharmaceuticals traded at $ 8.32 in the last session, which is +0.29 . The stock has a Range of 8.06 - 8.64. The stock has a 52 week low and high of 1.34 - 9.98 respectively.

    Comment?

  16. Stock Breakout Watch: Keryx Biopharmaceuticals (KERX), Target 10.5Read the original story

    Monday Apr 22 | SBWire

    The online StockConsultant latest screen has found provider of drugs to for the treatment of cancer Keryx Biopharmaceuticals stock under a breakout watch above 8.81. KERX stock price is up 4.9% to 8.42 with 89.3% higher volume and is completing a string of two strong days higher.

    Comment?

  17. Traders Favorite: Keryx Biopharmaceuticals, McDonald's Corporation,...Read the original story

    Monday Apr 22 | BayStreet.ca

    Keryx Biopharmaceuticals shares gained 5.48% to $8.47. The company, on March 11, announced its results for the fourth quarter and year ended December 31, 2012.

    Comment?

  18. Keryx, Zerenex, And IP Protection: A PropThink Conference CallRead the original story

    Monday Apr 22 | Seeking Alpha

    ... a leading patent attorney and former staff at the USPTO. The conference call centered around Keryx Biopharmaceuticals ( KERX ) and its lead drug candidate, Zerenex, which has come under scrutiny as questions have arisen about the drug's existing ...

    Comment?

  19. Keryx Biopharmaceuticals Inc. (NASDAQ:KERX), Celgene Corporation...Read the original story

    Monday Apr 22 | SBWire

    Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Keryx Biopharmaceuticals Inc.

    Comment?

  20. NASDAQ Gain Investor SupportRead the original story

    Monday Apr 22 | SBWire

    ... with over 4.3 million shares that have exchanged hands, will ACAD continue to push? Stay tuned. Keryx Biopharmaceuticals (NASDAQ:KERX) is slowly trending north, trading at an intraday of $8.4998 (+5.85%) with over 3.6 million share exchanged, will ...

    Comment?